Susquehanna International Group’s ALPS Medical Breakthroughs ETF SBIO Stock Holding History
Bought
Maintained
Sold
Other funds holding SBIO
CIS
GAM
MWM
SFS
Susquehanna International Group's SBIO Position: Q1 2026 in Review
Susquehanna International Group opened a new position in ALPS Medical Breakthroughs ETF (SBIO) in Q1 2026: 60,686 shares worth $3.18M. The stake represents ﹤0.01% of the portfolio and ranks #5161 among its holdings. This is a return to the name: Susquehanna International Group previously reported a position in SBIO as recently as Q3 2025.
Susquehanna International Group first reported a position in SBIO in Q2 2015 and has held it in 33 quarters since. 59 funds tracked by Wall St. Rank hold SBIO as of Q1 2026.
- Susquehanna International Group held 60,686 shares of ALPS Medical Breakthroughs ETF worth $3.18M as of Q1 2026.
- ALPS Medical Breakthroughs ETF was a new Susquehanna International Group position in Q1 2026.
- ALPS Medical Breakthroughs ETF made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #5161 holding.
- Susquehanna International Group first reported a position in ALPS Medical Breakthroughs ETF in Q2 2015 and has held it in 33 quarters since.
- 59 funds tracked by Wall St. Rank held ALPS Medical Breakthroughs ETF as of Q1 2026.
Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.